ID

35018

Beschreibung

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors; ODM derived from: https://clinicaltrials.gov/show/NCT02403271

Link

https://clinicaltrials.gov/show/NCT02403271

Stichworte

Versionen (1)
  1. 10.02.19 10.02.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

10. Februar 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT02403271

Englisch

Eligibility Breast Cancer NCT02403271

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. pathologically confirmed:
Beschreibung

Confirmed by Pathology

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0521093
UMLS CUI [1,2]
C0919386
non-small cell lung cancer (nsclc, adenocarcinoma or squamous-cell carcinoma) or
Beschreibung

Non-Small Cell Lung Carcinoma | Adenocarcinoma of lung | Squamous cell carcinoma of lung

Datentyp

boolean

Alias
UMLS CUI [1]
C0007131
UMLS CUI [2]
C0152013
UMLS CUI [3]
C0149782
breast cancer (her2 positive or triple negative) or
Beschreibung

HER2-positive carcinoma of breast | Triple Negative Breast Neoplasm

Datentyp

boolean

Alias
UMLS CUI [1]
C1960398
UMLS CUI [2]
C3539878
pancreatic cancer (adenocarcinoma)
Beschreibung

Pancreatic carcinoma | Adenocarcinoma of pancreas

Datentyp

boolean

Alias
UMLS CUI [1]
C0235974
UMLS CUI [2]
C0281361
2. relapsed or refractory disease (stage iii or iv): nsclc or pancreatic cancer must have failed at least 1 prior treatment. breast cancer must have failed at least 2 prior treatments.
Beschreibung

Recurrent disease TNM clinical staging | Refractory Disease TNM clinical staging | Non-Small Cell Lung Carcinoma | Pancreatic carcinoma | Prior Therapy Quantity failed | Breast Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0277556
UMLS CUI [1,2]
C3258246
UMLS CUI [2,1]
C1514815
UMLS CUI [2,2]
C3258246
UMLS CUI [3]
C0007131
UMLS CUI [4]
C0235974
UMLS CUI [5,1]
C1514463
UMLS CUI [5,2]
C1265611
UMLS CUI [5,3]
C0231175
UMLS CUI [6]
C0678222
3. measurable lesion by recist 1.1
Beschreibung

Measurable lesion

Datentyp

boolean

Alias
UMLS CUI [1]
C1513041
4. adequate hematologic function:
Beschreibung

Hematologic function

Datentyp

boolean

Alias
UMLS CUI [1]
C0221130
anc >1500 cells/mm3
Beschreibung

Absolute neutrophil count

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
platelet count >100,000 cells/mm3
Beschreibung

Platelet Count measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0032181
hgb >9.0 g/dl
Beschreibung

Hemoglobin measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0518015
5. adequate hepatic and renal function:
Beschreibung

Liver function | Renal function

Datentyp

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
ast and alt ≤2.5 x uln for subjects without liver metastases and ≤3.5 x uln for subjects with liver metastases
Beschreibung

Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver Absent | Secondary malignant neoplasm of liver

Datentyp

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
UMLS CUI [3,1]
C0494165
UMLS CUI [3,2]
C0332197
UMLS CUI [4]
C0494165
bilirubin ≤1.5 x uln (unless bilirubin rise is due to gilbert's syndrome or of non-hepatic origin)
Beschreibung

Serum total bilirubin measurement | Exception Elevated total bilirubin Due to Gilbert Disease

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0741494
UMLS CUI [2,3]
C0678226
UMLS CUI [2,4]
C0017551
creatinine ≤2.0 x uln or creatinine clearance ≥40 ml/min
Beschreibung

Creatinine measurement, serum | Creatinine clearance measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
UMLS CUI [2]
C0373595
6. pt/inr <1.5 x uln and ptt/ aptt <1.5 x uln
Beschreibung

Prothrombin time assay | International Normalized Ratio | Partial thromboplastin time | Activated Partial Thromboplastin Time measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0033707
UMLS CUI [2]
C0525032
UMLS CUI [3]
C1531697
UMLS CUI [4]
C0030605
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. mixed small cell and nsclc histology
Beschreibung

Histology Mixed | Small cell carcinoma of lung | Non-Small Cell Lung Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0344441
UMLS CUI [1,2]
C0205430
UMLS CUI [2]
C0149925
UMLS CUI [3]
C0007131
2. cns involvement of disease
Beschreibung

Central Nervous System Involvement Disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C4050309
UMLS CUI [1,2]
C0012634
3. anti-tumor therapy within 21 days of study day 1
Beschreibung

Cancer treatment

Datentyp

boolean

Alias
UMLS CUI [1]
C0920425
4. prior treatment with ibrutinib or other btk inhibitor and/or anti-pd1, anti-pd-l1, anti-pd-l2, anti-cd137 or ctla-4 antibody
Beschreibung

Ibrutinib | Bruton tyrosine kinase inhibitors | Anti-PD1 Monoclonal Antibody | Anti-PD-L1 Monoclonal Antibody | Other Coding | urelumab | Anti-CTLA-4 Monoclonal Antibody

Datentyp

boolean

Alias
UMLS CUI [1]
C3501358
UMLS CUI [2,1]
C0218158
UMLS CUI [2,2]
C0243077
UMLS CUI [3]
C4289970
UMLS CUI [4]
C4289971
UMLS CUI [5]
C3846158
UMLS CUI [6]
C1831875
UMLS CUI [7]
C4289973
5. history of allogeneic organ transplant
Beschreibung

Organ Transplantation Allogeneic

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0029216
UMLS CUI [1,2]
C1515895
6. treatment with a strong cytochrome p450 (cyp) 3a inhibitor
Beschreibung

CYP3A Inhibitors

Datentyp

boolean

Alias
UMLS CUI [1]
C3850056
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Breast Cancer NCT02403271

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Confirmed by Pathology
Item
1. pathologically confirmed:
boolean
C0521093 (UMLS CUI [1,1])
C0919386 (UMLS CUI [1,2])
Non-Small Cell Lung Carcinoma | Adenocarcinoma of lung | Squamous cell carcinoma of lung
Item
non-small cell lung cancer (nsclc, adenocarcinoma or squamous-cell carcinoma) or
boolean
C0007131 (UMLS CUI [1])
C0152013 (UMLS CUI [2])
C0149782 (UMLS CUI [3])
HER2-positive carcinoma of breast | Triple Negative Breast Neoplasm
Item
breast cancer (her2 positive or triple negative) or
boolean
C1960398 (UMLS CUI [1])
C3539878 (UMLS CUI [2])
Pancreatic carcinoma | Adenocarcinoma of pancreas
Item
pancreatic cancer (adenocarcinoma)
boolean
C0235974 (UMLS CUI [1])
C0281361 (UMLS CUI [2])
Recurrent disease TNM clinical staging | Refractory Disease TNM clinical staging | Non-Small Cell Lung Carcinoma | Pancreatic carcinoma | Prior Therapy Quantity failed | Breast Carcinoma
Item
2. relapsed or refractory disease (stage iii or iv): nsclc or pancreatic cancer must have failed at least 1 prior treatment. breast cancer must have failed at least 2 prior treatments.
boolean
C0277556 (UMLS CUI [1,1])
C3258246 (UMLS CUI [1,2])
C1514815 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
C0007131 (UMLS CUI [3])
C0235974 (UMLS CUI [4])
C1514463 (UMLS CUI [5,1])
C1265611 (UMLS CUI [5,2])
C0231175 (UMLS CUI [5,3])
C0678222 (UMLS CUI [6])
Measurable lesion
Item
3. measurable lesion by recist 1.1
boolean
C1513041 (UMLS CUI [1])
Hematologic function
Item
4. adequate hematologic function:
boolean
C0221130 (UMLS CUI [1])
Absolute neutrophil count
Item
anc >1500 cells/mm3
boolean
C0948762 (UMLS CUI [1])
Platelet Count measurement
Item
platelet count >100,000 cells/mm3
boolean
C0032181 (UMLS CUI [1])
Hemoglobin measurement
Item
hgb >9.0 g/dl
boolean
C0518015 (UMLS CUI [1])
Liver function | Renal function
Item
5. adequate hepatic and renal function:
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Secondary malignant neoplasm of liver Absent | Secondary malignant neoplasm of liver
Item
ast and alt ≤2.5 x uln for subjects without liver metastases and ≤3.5 x uln for subjects with liver metastases
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C0494165 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C0494165 (UMLS CUI [4])
Serum total bilirubin measurement | Exception Elevated total bilirubin Due to Gilbert Disease
Item
bilirubin ≤1.5 x uln (unless bilirubin rise is due to gilbert's syndrome or of non-hepatic origin)
boolean
C1278039 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0741494 (UMLS CUI [2,2])
C0678226 (UMLS CUI [2,3])
C0017551 (UMLS CUI [2,4])
Creatinine measurement, serum | Creatinine clearance measurement
Item
creatinine ≤2.0 x uln or creatinine clearance ≥40 ml/min
boolean
C0201976 (UMLS CUI [1])
C0373595 (UMLS CUI [2])
Prothrombin time assay | International Normalized Ratio | Partial thromboplastin time | Activated Partial Thromboplastin Time measurement
Item
6. pt/inr <1.5 x uln and ptt/ aptt <1.5 x uln
boolean
C0033707 (UMLS CUI [1])
C0525032 (UMLS CUI [2])
C1531697 (UMLS CUI [3])
C0030605 (UMLS CUI [4])
Item Group
C0680251 (UMLS CUI)
Histology Mixed | Small cell carcinoma of lung | Non-Small Cell Lung Carcinoma
Item
1. mixed small cell and nsclc histology
boolean
C0344441 (UMLS CUI [1,1])
C0205430 (UMLS CUI [1,2])
C0149925 (UMLS CUI [2])
C0007131 (UMLS CUI [3])
Central Nervous System Involvement Disease
Item
2. cns involvement of disease
boolean
C4050309 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
Cancer treatment
Item
3. anti-tumor therapy within 21 days of study day 1
boolean
C0920425 (UMLS CUI [1])
Ibrutinib | Bruton tyrosine kinase inhibitors | Anti-PD1 Monoclonal Antibody | Anti-PD-L1 Monoclonal Antibody | Other Coding | urelumab | Anti-CTLA-4 Monoclonal Antibody
Item
4. prior treatment with ibrutinib or other btk inhibitor and/or anti-pd1, anti-pd-l1, anti-pd-l2, anti-cd137 or ctla-4 antibody
boolean
C3501358 (UMLS CUI [1])
C0218158 (UMLS CUI [2,1])
C0243077 (UMLS CUI [2,2])
C4289970 (UMLS CUI [3])
C4289971 (UMLS CUI [4])
C3846158 (UMLS CUI [5])
C1831875 (UMLS CUI [6])
C4289973 (UMLS CUI [7])
Organ Transplantation Allogeneic
Item
5. history of allogeneic organ transplant
boolean
C0029216 (UMLS CUI [1,1])
C1515895 (UMLS CUI [1,2])
CYP3A Inhibitors
Item
6. treatment with a strong cytochrome p450 (cyp) 3a inhibitor
boolean
C3850056 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video